Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502377 (N-[4-(7- methoxy-1- methyl- [1,2,4]tri- azolo[4,3-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502344 (2-methoxy-N- {4-[1-methyl- 7-(1-methyl- 1H-benzo- ...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502348 (3-methyl-N- {4-[1-methyl- 7-(1-propyl- 1H- benzoim...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502479 ((S)-(1-{4-[7- (2-methoxy- ethoxy)-1- methyl- [1,2,...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502480 ((S)-(1-{4-[7- (2-methoxy- ethoxy)-1- methyl- [1,2,...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502328 (US11028090, Example 222) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502494 (2,3- dichloro-N- {4-[7-(2- methoxy- ethoxy)-1- met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502334 (N-{4-[7-(5,6- dimethoxy- 1H-benzo- imidazole-2- yl...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502481 ((S)-(1-{4-[7- (2-methoxy- ethoxy)-1- methyl- [1,2,...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502471 (2-(S)- hydroxy-N- {4-[7-(2- methoxy- ethoxy)-1- me...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502501 (N-{4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]tri...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502340 (2,2-difluoro- N-{4-[1- methyl-7-(1- methyl-1H- ben...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502290 (US11028090, Example 176 | [4-(7,8- diethoxy-1- met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502455 (US11028090, Example 372 | {4-[7-(2- methoxy- ethox...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502217 (N-[4-(7,8- dimethoxy-1- methyl-[1,2,4] triazolo[4,...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502343 (4-methyl- pentanoic acid-{4-[1- methyl-7- (1-meth...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502475 (3-cyclopentyl- N-{4-[7-(2- methoxy- ethoxy)-1- met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502466 (4-methyl- pentanoic acid{4-[7- (2-methoxy- ethoxy)...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502336 (US11028090, Example 229 | {4-[1-methyl- 7-(1-methy...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502502 (1-isopropyl-3- {4-[7-(2- methoxy- ethoxy)-1- methy...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502449 (US11028090, Example 366 | US11028090, Example 428 ...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502331 (N-{4-[7-(1H- benzo- imidazole-2- yl)-1-methyl- [1,...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502392 (2-(R)- hydroxy-N- [4-(7- methoxy-1- methyl- [1,2,4...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502288 (US11028090, Example 173 | [4-(7,8- diethoxy-1- met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502252 (2-(S)-hydroxy-N- [4-(8-methoxy- 1-methyl-[1,2,4] t...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502276 (US11028090, Example 161 | [4-(8- methoxy-1,6- dime...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502412 ((S)-{1-[4- (7-methoxy- 1-methyl- [1,2,4]tri- azolo...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502637 (US11028090, Example 579) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502640 (US11028090, Example 583) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502641 (N-{4-[7- (3,5- dimethyl- isoxazol-4- yl)-1- methyl...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502473 (2,2- difluoro-N- {4-[7-(2- methoxy- ethoxy)-1- met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502527 (US11028090, Example 448) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502213 (4-methyl- pentanoic acid [4-(7,8- dimethoxy-1- met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502566 (4-(7- imidazole- 1-yl-1- methyl- [1,2,4]triazolo[4...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502450 (US11028090, Example 367 | US11028090, Example 368 ...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502465 (N-{4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]tri...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502656 (US11028090, Example 622 | US11028090, Example 623 ...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502157 (2-(S)- hydroxy-N- [4-(1- methyl- [1,2,4] triazolo ...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502557 (2-(S)- hydroxy-N- [4-(7- methoxy-1- methyl-8- trif...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502470 (2-(R)- hydroxy-N- {4-[7-(2- methoxy- ethoxy)-1- me...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502261 (2-(S)- hydroxy-N- [4-(6- methoxy- 1,7- dimethyl- [...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502179 (US11028090, Example 39) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502341 (2-(S)- hydroxy-3- methyl-N-{4- [1-methyl-7- (1-met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502623 (N-[4-(7- methoxy-1- methyl-8- propylamino- [1,2,4]...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502643 (N-{4-[7- (3,5- dimethyl- isoxazol-4- yl)-1- methyl...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502477 ((1-{4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]tr...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502488 (N-{4-[7-(2- methoxy- ethoxy)-1- methyl- [1,2,4]tri...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502335 (US11028090, Example 228 | {4-[1-methyl- 7-(1-methy...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502196 (US11028090, Example 62 | [4-(7,8- dimethoxy- 1-met...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 (Homo sapiens (Human)) | BDBM502360 (N-{4-[7-(3- cyano- propylamino)- 1-methyl- [1,2,4]...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Dong Wha Pharm. Co., Ltd.; Korea Research Institute of Chemical Technology US Patent | Assay Description The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th... | US Patent US11028090 (2021) BindingDB Entry DOI: 10.7270/Q22J6G0T | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 505 total ) | Next | Last >> |